FORUM HEALTH PRODUCTS LTD.Active
Key figures
Ratios
2025Balance sheet structure
Dividends
from the accountsDividends paid in the financial year: £950,000 (114% of the profit for the year).
Filed accounts2023–2025
| 2023 | 2025 | |
|---|---|---|
| Turnover | — | 88,155,979 |
| Profit for the year | 935,791 | 829,909 |
| Cash at bank and in hand | 2,022,754 | 57,290 |
| Total assets | 16,143,958 | 17,191,392 |
| Total liabilities | 14,474,781 | 16,338,285 |
| Net assets / total equity | 1,669,177 | 853,107 |
| Average number of employees | 5 | 0 |
| Average pay (per year) | 44,232 | — |
| Dividends paid | 1,275,000 | 950,000 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2025The principal activity of the company in the year under review was distribution of Department of Health prescription products.
As described in the company's latest filed accounts.
Summary: FORUM HEALTH PRODUCTS LTD.
Company
FORUM HEALTH PRODUCTS LTD. is a private limited company registered with Companies House under company number 01592283. It was incorporated on 19 Oct 1981. Its status is active. The registered office is in Reigate (RH2). Its nature of business (SIC 2007) is agents specialized in the sale of other particular products (46180).
Accounts
The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files full accounts. Turnover was £88,155,979. Profit for the year was £829,909. Net assets were £853,107, down 48.9% on the previous year. Cash at bank and in hand was £57,290. Total assets were £17,191,392 and total liabilities £16,338,285. The company had an average of 0 employees. Figures are available for 2 financial years (2023–2025).
Control and charges
One person with significant control is registered. 1 of 4 registered charges are outstanding.
Filing deadlines
The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 8 Jan 2027.